Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Response letter to: "hypocoagulable" thromboelastography profiles in patients with cyanotic congenital heart disease: facts or technical artifacts?

Jensen AS, Johansson PI, Bochsen L, Idorn L, Sørensen KE, Thilén U, Nagy E, Furenäs E, Søndergaard L.

Int J Cardiol. 2013 Oct 9;168(4):4426. doi: 10.1016/j.ijcard.2013.05.009. Epub 2013 May 23. No abstract available.

PMID:
23706329
2.

"Hypocoagulable" thromboelastography profiles in patients with cyanotic congenital heart disease: facts or technical artifacts?

Spiezia L, Campello E, Simioni P.

Int J Cardiol. 2013 Oct 3;168(3):2914. doi: 10.1016/j.ijcard.2013.03.105. Epub 2013 Apr 19. No abstract available.

PMID:
23608403
3.

Fibrinogen function is impaired in whole blood from patients with cyanotic congenital heart disease.

Jensen AS, Johansson PI, Bochsen L, Idorn L, Sørensen KE, Thilén U, Nagy E, Furenäs E, Søndergaard L.

Int J Cardiol. 2013 Sep 1;167(5):2210-4. doi: 10.1016/j.ijcard.2012.06.019. Epub 2012 Jun 22.

PMID:
22727966
4.

The haematocrit--an important factor causing impaired haemostasis in patients with cyanotic congenital heart disease.

Jensen AS, Johansson PI, Idorn L, Sørensen KE, Thilén U, Nagy E, Furenäs E, Søndergaard L.

Int J Cardiol. 2013 Aug 20;167(4):1317-21. doi: 10.1016/j.ijcard.2012.03.181. Epub 2012 May 10.

PMID:
22578951
5.

High haematocrit in cyanotic congenital heart disease affects how fibrinogen activity is determined by rotational thromboelastometry.

Westbury SK, Lee K, Reilly-Stitt C, Tulloh R, Mumford AD.

Thromb Res. 2013 Aug;132(2):e145-51. doi: 10.1016/j.thromres.2013.07.006. Epub 2013 Jul 30.

PMID:
23906940
6.

Whole blood coagulation measured by modified thrombelastography (ROTEM) is impaired in infants with congenital heart diseases.

Osthaus WA, Boethig D, Johanning K, Rahe-Meyer N, Theilmeier G, Breymann T, Suempelmann R.

Blood Coagul Fibrinolysis. 2008 Apr;19(3):220-5. doi: 10.1097/MBC.0b013e3282f54532.

PMID:
18388502
7.

[Changes in the coagulation and anticoagulation system of the blood in patients with congenital defects of the heart of the cyanotic type].

Iufit SE, Zargarli FI, Tolpekin VE.

Kardiologiia. 1967 Mar;7(3):136-7. Russian. No abstract available.

PMID:
5604602
8.

Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery.

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Artif Organs. 2010 Nov;34(11):955-60. doi: 10.1111/j.1525-1594.2010.01148.x.

PMID:
21092037
9.

Hemostasis in cyanotic congenital heart disease.

Ekert H, Gilchrist GS, Stanton R, Hammond D.

J Pediatr. 1970 Feb;76(2):221-30. No abstract available.

PMID:
5410170
10.

Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both?

Karlsson O, Jeppsson A, Hellgren M.

Int J Obstet Anesth. 2014 Feb;23(1):10-7. doi: 10.1016/j.ijoa.2013.07.003. Epub 2013 Dec 15.

PMID:
24342222
11.

[Hemostatic changes in congenital heart diseases].

Hrodek O, Padovcová H, Vorísková M.

Cesk Pediatr. 1972 Feb;27(2):59-63. Czech. No abstract available.

PMID:
5010878
12.

Perioperative monitoring of thromboelastograph on hemostasis and therapy for cyanotic infants undergoing complex cardiac surgery.

Cui Y, Hei F, Long C, Feng Z, Zhao J, Yan F, Wang Y, Liu J.

Artif Organs. 2009 Nov;33(11):909-14. doi: 10.1111/j.1525-1594.2009.00914.x.

PMID:
20021469
13.

Neutrophil activation and morbidity in young adults with cyanotic congenital heart disease.

McLeod KA, Martin P, Williams G, Walker DR.

Blood Coagul Fibrinolysis. 1994 Feb;5(1):17-22.

PMID:
8180336
14.

Coagulation in cyanotic congenital heart disease.

Wedemeyer AL, Edson JR, Krivit W.

Am J Dis Child. 1972 Nov;124(5):656-60. No abstract available.

PMID:
5085479
15.

The relationship among thromboelastography, hemostatic variables, and bleeding after cardiopulmonary bypass surgery in children.

Moganasundram S, Hunt BJ, Sykes K, Holton F, Parmar K, Durward A, Murdoch IA, Austin C, Anderson D, Tibby SM.

Anesth Analg. 2010 Apr 1;110(4):995-1002. doi: 10.1213/ANE.0b013e3181cd6d20. Epub 2010 Feb 8.

PMID:
20142345
16.

[THE COMPARATIVE CHARACTERISTIC OF KAOLIN-ACTIVATED THROMBOELASTOGRAPHY IN HEALTHY NEWBORNS AND NEWBORNS WITH HEART AILMENTS].

Leonov NP, Karas'kov AM, Litasova EE, Strunin OV, Karmadonova NA, Akopov GD, Vishegorodtseva LI.

Klin Lab Diagn. 2016 Feb;61(2):87-90. Russian.

PMID:
27455561
17.

Haemostatic defects in cyanotic congenital heart disease.

Henriksson P, Värendh G, Lundström NR.

Br Heart J. 1979 Jan;41(1):23-7.

18.

Hypernatremia in a patient with cyanotic congenital heart disease.

Capel I, Subirana MT, Rodríguez-Espinosa J, Corcoy R.

Int J Cardiol. 2008 Jul 21;127(3):e116-7. Epub 2007 Aug 30. No abstract available.

PMID:
17764765
19.

The effect of acetylsalicylic acid on platelet function in cyanotic congenital heart disease.

Goldschmidt B, Sorland SJ, Bjornstad PG.

Acta Paediatr Scand. 1974 Nov;63(6):869-74. No abstract available.

PMID:
4611136
20.

[Normal hemoglobin levels in children with cyanotic heart disease. Is it iron deficiency anemia?].

Hågå P.

Tidsskr Nor Laegeforen. 1993 May 30;113(14):1710-1. Norwegian.

PMID:
8322297

Supplemental Content

Support Center